TP53 and cervical carcinoma: Previous studies have implicated somatic mutations in PIK3CA, TP53, STK11, EP300, FBXW7, and HLA-B in the pathogenesis of cervical carcinomas (Ojesina et al., 2014; Bager et al., 2015).